MedTrace Logo

Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas

NCT00639405 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2011-04-27

No results posted yet for this study

Summary

The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have already had surgery over the course of one year.

Conditions

  • Parathyroid Neoplasm
  • Parathyroid Diseases

Sponsors & Collaborators

  • State University of New York - Upstate Medical University

    lead OTHER

Principal Investigators

  • Michele Lisi, MD · State University of New York - Upstate Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00639405 on ClinicalTrials.gov